Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Anai

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Oncology Letters|April 2, 2019
Prognostic impact of tumor-infiltrating CD276/Foxp3-positive lymphocytes and associated circulating cytokines in patients undergoing radical nephrectomy for localized renal cell carcinomaKota Iida, Makito Miyake, Kenta Onishi, et al.
Research and Reports in Urology|April 3, 2019
Comparison of cancer detection rates by transrectal prostate biopsy for prostate cancer using two different nomograms based on patient's age and prostate volumeShunta Hori, Nobumichi Tanaka, Yasushi Nakai, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 11, 2021
Impact of neoadjuvant androgen deprivation therapy on postimplant prostate D90 and prostate volume after low-dose-rate brachytherapy for localized prostate cancerTakuya Owari, Nobumichi Tanaka, Yasushi Nakai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2015
Changes in lower urinary tract symptoms and quality of life after salvage radiotherapy for biochemical recurrence of prostate cancerMakito Miyake, Nobumichi Tanaka, Isao Asakawa, et al.
Clinical and Translational Radiation Oncology|December 15, 2018
Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancerKenta Onishi, Nobumichi Tanaka, Makito Miyake, et al.
Diagnostics (Basel, Switzerland)|May 21, 2020
Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with PembrolizumabTakuto Shimizu, Makito Miyake, Shunta Hori, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 5, 2021
Video-urodynamic effects of vibegron, a new selective β3-adrenoceptor agonist, on antimuscarinic-resistant neurogenic bladder dysfunction in patients with spina bifidaKatsuya Aoki, Hitoshi Momose, Daisuke Gotoh, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 5, 2020
Trends in treatment outcomes of hydrocele in Japanese children: A single-institute experienceShunta Hori, Katsuya Aoki, Kazuki Ichikawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 27, 2020
Biochemical control of the combination of cyclooxygenase-2 inhibitor and <sup>125</sup> I-brachytherapy for prostate cancer: Post hoc analysis of an open-label controlled randomized trialYasushi Nakai, Nobumichi Tanaka, Isao Asakawa, et al.
Molecular Cancer Therapeutics|July 16, 2005
p37 Induces tumor invasivenessCatherine M Ketcham, Satoshi Anai, Robbie Reutzel, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Oncology Letters|April 2, 2019
Prognostic impact of tumor-infiltrating CD276/Foxp3-positive lymphocytes and associated circulating cytokines in patients undergoing radical nephrectomy for localized renal cell carcinomaKota Iida, Makito Miyake, Kenta Onishi, et al.
Research and Reports in Urology|April 3, 2019
Comparison of cancer detection rates by transrectal prostate biopsy for prostate cancer using two different nomograms based on patient's age and prostate volumeShunta Hori, Nobumichi Tanaka, Yasushi Nakai, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 11, 2021
Impact of neoadjuvant androgen deprivation therapy on postimplant prostate D90 and prostate volume after low-dose-rate brachytherapy for localized prostate cancerTakuya Owari, Nobumichi Tanaka, Yasushi Nakai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2015
Changes in lower urinary tract symptoms and quality of life after salvage radiotherapy for biochemical recurrence of prostate cancerMakito Miyake, Nobumichi Tanaka, Isao Asakawa, et al.
Clinical and Translational Radiation Oncology|December 15, 2018
Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancerKenta Onishi, Nobumichi Tanaka, Makito Miyake, et al.
Diagnostics (Basel, Switzerland)|May 21, 2020
Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with PembrolizumabTakuto Shimizu, Makito Miyake, Shunta Hori, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 5, 2021
Video-urodynamic effects of vibegron, a new selective β3-adrenoceptor agonist, on antimuscarinic-resistant neurogenic bladder dysfunction in patients with spina bifidaKatsuya Aoki, Hitoshi Momose, Daisuke Gotoh, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 5, 2020
Trends in treatment outcomes of hydrocele in Japanese children: A single-institute experienceShunta Hori, Katsuya Aoki, Kazuki Ichikawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 27, 2020
Biochemical control of the combination of cyclooxygenase-2 inhibitor and <sup>125</sup> I-brachytherapy for prostate cancer: Post hoc analysis of an open-label controlled randomized trialYasushi Nakai, Nobumichi Tanaka, Isao Asakawa, et al.
Molecular Cancer Therapeutics|July 16, 2005
p37 Induces tumor invasivenessCatherine M Ketcham, Satoshi Anai, Robbie Reutzel, et al.
Pageof 18